Fig. 2From: Pharmacokinetics of carfilzomib in patients with advanced malignancies and varying degrees of hepatic impairment: an open-label, single-arm, phase 1 studyMean (+SD) plasma concentration–time profiles of carfilzomib following IV administration of carfilzomib (linear and semi-log plots; PK-evaluable population). IV intravenous, PK pharmacokinetic, SD standard deviationBack to article page